Navigation Links
Hillcrest Completes Purchase of SouthCrest & Claremore Hospitals
Date:9/1/2011

TULSA, Okla., Sept. 1, 2011 /PRNewswire/ -- Hillcrest HealthCare System (HHS) has successfully completed the purchase of SouthCrest Hospital in Tulsa, Okla., and Claremore Regional Hospital in Claremore, Okla.  The price and financial terms of the agreement were not disclosed.

The transaction included the assets and operations of the 180-bed SouthCrest Hospital, the 89-bed Claremore Regional Hospital, more than 70 primary care physicians, specialists and mid-level providers and 1,100 employees.

"This is a milestone day for Hillcrest, its patients and residents of south Tulsa and Rogers County," said Kevin J. Gross, CEO of HHS and president of the Oklahoma Division of Ardent Health Services.  "We can now provide more access to quality health care for our patients, offer a network of 230 exceptional physicians and begin to invest and expand the capabilities at both SouthCrest and Claremore Regional."

The first part of that expansion is already under way.  The construction of two new heart catheterization labs has begun at SouthCrest Hospital.  It's an investment of $3.2 million.  At Claremore Regional, interventional cath procedures will be introduced later this month and an $800,000 internal facilities update will soon be completed that includes walls, floors and ceiling renovations.

HHS has also appointed Joseph Neely as chief executive officer of SouthCrest Hospital.  Neely brings more than 35 years of experience in health care administration to SouthCrest – much of it in south Tulsa.  Neely was previously senior vice president and administrator for Saint Francis Hospital South.  He also worked more than six years for HHS in the late 1990s.

"Joe is a team-builder and is proven in developing great relationships with physicians," said Gross.  "He will be a benefit to our patients, our employees and this community as we begin a new era at SouthCrest."

In the coming weeks and months, Gross and his management team will work closely with physicians and members of leadership at SouthCrest and Claremore Regional to create and implement a smooth transition that will enhance patient services and quality.

The acquisition is another example of investment in Tulsa and Oklahoma by Hillcrest's parent company, Ardent Health Services.  To date, more than $265 million has been invested into Hillcrest's facilities, equipment and people since 2004.

About Hillcrest HealthCare System

Hillcrest HealthCare System (HHS) is one of eastern Oklahoma's leading health care providers.  More than 5,000 HHS employees work each day to provide compassionate, innovative and high-quality health care in the communities they serve throughout the state.  HHS is a comprehensive system comprised of Hillcrest Medical Center in Tulsa, Oklahoma Heart Institute, SouthCrest Hospital, Bailey Medical Center in Owasso, Claremore Regional Hospital, Henryetta Medical Center, Cushing Regional Hospital, SouthCrest Medical Group, Northeast Oklahoma Medical Group and one of Oklahoma's largest physician groups - Utica Park Clinic.

Media Contact/For More Information:

Angela Peterson, Media & Public Relations Manager, Hillcrest HealthCare System

918.579.5203 (office) or 918.605.3573 (media cell phone) or anpeters@hillcrest.com


'/>"/>
SOURCE Hillcrest HealthCare System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... March 28, 2017 The global emerging cancer ... of 13.45% from 2016 to 2023 and reach a ... Cancer is a chronic disease and is affecting ... cancer diagnostics market. This report is focused on emerging ... market growth is propelled due to factors such as: ...
(Date:3/28/2017)... NEW YORK , March 28, 2017 "Chemotherapy Induced ... an overview of the disease and global market trends of the ... United States , Europe ( ... , Spain , UK) and ... (RoE) and rest of the world (RoW). ...
(Date:3/28/2017)... March 28, 2017  Las Vegas ophthalmology practice, Center ... Gel Stent (Allergan, Dublin ), an ... eye, thereby reducing intraocular pressure in patients with moderate ... are affected by glaucoma that can lead to progressive ... blindness, if left untreated. According to the ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology ... two biometric time and attendance tracking products: the new NCheck Cloud Bio Attendance ... Bio Attendance uses biometric face recognition to enable users to check in and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Self-Funding Success website has recently developed and published an informational resource that ... was created based on common inquiries the site’s team of third party administrator ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... 2017 , ... Public relations pros work hard to earn placements and ... While many results are clear, much of PR is hard to quantify. Goal-setting and ... to measurement, firms should always take an all-inclusive approach that takes both traditional and ...
Breaking Medicine News(10 mins):